Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis

Rosemary Ekong, Mark Nellist, Marianne Hoogeveen-Westerveld, Marjolein Wentink, Jessica Panzer, Steven Sparagana, Warren Emmett, Natalie L. Dawson, Marie Claire Malinge, Rima Nabbout, Caterina Carbonara, Marco Barberis, Sergio Padovan, Marta Futema, Vincent Plagnol, Steve E. Humphries, Nicola Migone, Sue Povey

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Inactivating mutations in TSC1 and TSC2 cause tuberous sclerosis complex (TSC). The 2012 international consensus meeting on TSC diagnosis and management agreed that the identification of a pathogenic TSC1 or TSC2 variant establishes a diagnosis of TSC, even in the absence of clinical signs. However, exons 25 and 31 of TSC2 are subject to alternative splicing. No variants causing clinically diagnosed TSC have been reported in these exons, raising the possibility that such variants would not cause TSC. We present truncating and in-frame variants in exons 25 and 31 in three individuals unlikely to fulfil TSC diagnostic criteria and examine the importance of these exons in TSC using different approaches. Amino acid conservation analysis suggests significantly less conservation in these exons compared with the majority of TSC2 exons, and TSC2 expression data demonstrates that the majority of TSC2 transcripts lack exons 25 and/or 31 in many human adult tissues. In vitro assay of both exons shows that neither exon is essential for TSC complex function. Our evidence suggests that variants in TSC2 exons 25 or 31 are very unlikely to cause classical TSC, although a role for these exons in tissue/stage specific development cannot be excluded.

Original languageEnglish (US)
Pages (from-to)364-370
Number of pages7
JournalHuman Mutation
Volume37
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Tuberous Sclerosis
Exons
Alternative Splicing

Keywords

  • Alternative splicing
  • Diagnosis
  • TSC2
  • Tuberous sclerosis
  • Variants

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Ekong, R., Nellist, M., Hoogeveen-Westerveld, M., Wentink, M., Panzer, J., Sparagana, S., ... Povey, S. (2016). Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis. Human Mutation, 37(4), 364-370. https://doi.org/10.1002/humu.22951

Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis. / Ekong, Rosemary; Nellist, Mark; Hoogeveen-Westerveld, Marianne; Wentink, Marjolein; Panzer, Jessica; Sparagana, Steven; Emmett, Warren; Dawson, Natalie L.; Malinge, Marie Claire; Nabbout, Rima; Carbonara, Caterina; Barberis, Marco; Padovan, Sergio; Futema, Marta; Plagnol, Vincent; Humphries, Steve E.; Migone, Nicola; Povey, Sue.

In: Human Mutation, Vol. 37, No. 4, 01.04.2016, p. 364-370.

Research output: Contribution to journalArticle

Ekong, R, Nellist, M, Hoogeveen-Westerveld, M, Wentink, M, Panzer, J, Sparagana, S, Emmett, W, Dawson, NL, Malinge, MC, Nabbout, R, Carbonara, C, Barberis, M, Padovan, S, Futema, M, Plagnol, V, Humphries, SE, Migone, N & Povey, S 2016, 'Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis', Human Mutation, vol. 37, no. 4, pp. 364-370. https://doi.org/10.1002/humu.22951
Ekong, Rosemary ; Nellist, Mark ; Hoogeveen-Westerveld, Marianne ; Wentink, Marjolein ; Panzer, Jessica ; Sparagana, Steven ; Emmett, Warren ; Dawson, Natalie L. ; Malinge, Marie Claire ; Nabbout, Rima ; Carbonara, Caterina ; Barberis, Marco ; Padovan, Sergio ; Futema, Marta ; Plagnol, Vincent ; Humphries, Steve E. ; Migone, Nicola ; Povey, Sue. / Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis. In: Human Mutation. 2016 ; Vol. 37, No. 4. pp. 364-370.
@article{7457f44a0bce416db0c690dc68ff2d95,
title = "Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis",
abstract = "Inactivating mutations in TSC1 and TSC2 cause tuberous sclerosis complex (TSC). The 2012 international consensus meeting on TSC diagnosis and management agreed that the identification of a pathogenic TSC1 or TSC2 variant establishes a diagnosis of TSC, even in the absence of clinical signs. However, exons 25 and 31 of TSC2 are subject to alternative splicing. No variants causing clinically diagnosed TSC have been reported in these exons, raising the possibility that such variants would not cause TSC. We present truncating and in-frame variants in exons 25 and 31 in three individuals unlikely to fulfil TSC diagnostic criteria and examine the importance of these exons in TSC using different approaches. Amino acid conservation analysis suggests significantly less conservation in these exons compared with the majority of TSC2 exons, and TSC2 expression data demonstrates that the majority of TSC2 transcripts lack exons 25 and/or 31 in many human adult tissues. In vitro assay of both exons shows that neither exon is essential for TSC complex function. Our evidence suggests that variants in TSC2 exons 25 or 31 are very unlikely to cause classical TSC, although a role for these exons in tissue/stage specific development cannot be excluded.",
keywords = "Alternative splicing, Diagnosis, TSC2, Tuberous sclerosis, Variants",
author = "Rosemary Ekong and Mark Nellist and Marianne Hoogeveen-Westerveld and Marjolein Wentink and Jessica Panzer and Steven Sparagana and Warren Emmett and Dawson, {Natalie L.} and Malinge, {Marie Claire} and Rima Nabbout and Caterina Carbonara and Marco Barberis and Sergio Padovan and Marta Futema and Vincent Plagnol and Humphries, {Steve E.} and Nicola Migone and Sue Povey",
year = "2016",
month = "4",
day = "1",
doi = "10.1002/humu.22951",
language = "English (US)",
volume = "37",
pages = "364--370",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis

AU - Ekong, Rosemary

AU - Nellist, Mark

AU - Hoogeveen-Westerveld, Marianne

AU - Wentink, Marjolein

AU - Panzer, Jessica

AU - Sparagana, Steven

AU - Emmett, Warren

AU - Dawson, Natalie L.

AU - Malinge, Marie Claire

AU - Nabbout, Rima

AU - Carbonara, Caterina

AU - Barberis, Marco

AU - Padovan, Sergio

AU - Futema, Marta

AU - Plagnol, Vincent

AU - Humphries, Steve E.

AU - Migone, Nicola

AU - Povey, Sue

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Inactivating mutations in TSC1 and TSC2 cause tuberous sclerosis complex (TSC). The 2012 international consensus meeting on TSC diagnosis and management agreed that the identification of a pathogenic TSC1 or TSC2 variant establishes a diagnosis of TSC, even in the absence of clinical signs. However, exons 25 and 31 of TSC2 are subject to alternative splicing. No variants causing clinically diagnosed TSC have been reported in these exons, raising the possibility that such variants would not cause TSC. We present truncating and in-frame variants in exons 25 and 31 in three individuals unlikely to fulfil TSC diagnostic criteria and examine the importance of these exons in TSC using different approaches. Amino acid conservation analysis suggests significantly less conservation in these exons compared with the majority of TSC2 exons, and TSC2 expression data demonstrates that the majority of TSC2 transcripts lack exons 25 and/or 31 in many human adult tissues. In vitro assay of both exons shows that neither exon is essential for TSC complex function. Our evidence suggests that variants in TSC2 exons 25 or 31 are very unlikely to cause classical TSC, although a role for these exons in tissue/stage specific development cannot be excluded.

AB - Inactivating mutations in TSC1 and TSC2 cause tuberous sclerosis complex (TSC). The 2012 international consensus meeting on TSC diagnosis and management agreed that the identification of a pathogenic TSC1 or TSC2 variant establishes a diagnosis of TSC, even in the absence of clinical signs. However, exons 25 and 31 of TSC2 are subject to alternative splicing. No variants causing clinically diagnosed TSC have been reported in these exons, raising the possibility that such variants would not cause TSC. We present truncating and in-frame variants in exons 25 and 31 in three individuals unlikely to fulfil TSC diagnostic criteria and examine the importance of these exons in TSC using different approaches. Amino acid conservation analysis suggests significantly less conservation in these exons compared with the majority of TSC2 exons, and TSC2 expression data demonstrates that the majority of TSC2 transcripts lack exons 25 and/or 31 in many human adult tissues. In vitro assay of both exons shows that neither exon is essential for TSC complex function. Our evidence suggests that variants in TSC2 exons 25 or 31 are very unlikely to cause classical TSC, although a role for these exons in tissue/stage specific development cannot be excluded.

KW - Alternative splicing

KW - Diagnosis

KW - TSC2

KW - Tuberous sclerosis

KW - Variants

UR - http://www.scopus.com/inward/record.url?scp=84960493526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960493526&partnerID=8YFLogxK

U2 - 10.1002/humu.22951

DO - 10.1002/humu.22951

M3 - Article

C2 - 26703369

AN - SCOPUS:84960493526

VL - 37

SP - 364

EP - 370

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -